You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Atezolizumab

Showing 1 - 25 of 765
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Glioblastoma Trial (Atezolizumab)

Not yet recruiting
  • Recurrent Glioblastoma
  • Atezolizumab
  • (no location specified)
Oct 3, 2023

Hepatocellular Carcinoma Non-resectable Trial in Taoyuan City (Atezolizumab, Bevacizumab, Proton radiotherapy)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Atezolizumab
  • +2 more
  • Taoyuan City, Taiwan
    Chang Gung Memorial Hospital at Linkou
Nov 17, 2023

Large Cell Neuroendocrine Carcinoma of the Lung Trial in Athens (Atezolizumab, Carboplatin, Etoposide)

Completed
  • Large Cell Neuroendocrine Carcinoma of the Lung
  • Atezolizumab
  • +2 more
  • Athens, Greece
  • +1 more
Sep 16, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma Non-resectable Trial in Seoul (Atezolizumab plus

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab plus bevacizumab, combined EBRT to vascular invasion
  • Atezolizumab plus bevacizumab
  • Seoul, Korea, Republic of
    Asan Medical Center
Aug 7, 2023

Colorectal Cancer Trial (all trans Retinoic Acid, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • all trans Retinoic Acid
  • +2 more
  • (no location specified)
Aug 11, 2023

Patterns of Transcatheter Arterial Chemoembolization Combined

Not yet recruiting
  • HCC
  • (no location specified)
Aug 29, 2023

Metastatic Microsatellite-stable Colorectal Cancer Trial (LB-100, Atezolizumab)

Not yet recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • (no location specified)
Sep 1, 2023

Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor Thrombus Trial (I-125 Seeds Brachytherapy in PVTT,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • I-125 Seeds Brachytherapy in PVTT
  • +2 more
  • (no location specified)
Aug 14, 2023

Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)

Not yet recruiting
  • Metastatic Hepatocellular Carcinoma
  • Atezolizumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2023

Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

Withdrawn
  • Advanced Solid Tumor
  • +9 more
  • (no location specified)
Oct 16, 2023

Triple Negative Breast Tumors Trial in Paris (Atezolizumab + RP1)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Atezolizumab + RP1
  • Paris, France
    Institut Curie
Oct 2, 2023

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Los Angeles (Atezolizumab

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +10 more
  • Atezolizumab and Recombinant Human Hyaluronidase
  • Survey Administration
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Jan 31, 2023

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)

Not yet recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Stage IV Lung Cancer
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Oct 25, 2023

Hepatocellular Carcinoma Trial in Seoul (Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Seoul, Korea, Republic of
    Asan Medical Center
Nov 14, 2023

Hepatocellular Carcinoma Trial (Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 18, 2023

Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Richter's Transformation
  • Boston, Massachusetts
  • +1 more
Sep 12, 2023

NSCLC Trial (Atezolizumab, Tiragolumab)

Not yet recruiting
  • NSCLC
  • (no location specified)
Apr 5, 2023

Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Atezolizumab
  • +3 more
  • (no location specified)
Jun 14, 2023

Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors Trial (RO7566802, Atezolizumab)

Not yet recruiting
  • Locally Advanced Solid Tumors
  • +2 more
  • (no location specified)
Sep 4, 2023

Solid Tumor, Adult Trial in Albury (Tiragolumab, Atezolizumab)

Not yet recruiting
  • Solid Tumor, Adult
  • Tiragolumab
  • Atezolizumab
  • Albury, New South Wales, Australia
  • +1 more
Aug 22, 2023

HPV-Related Cervical Carcinoma, HPV-Related Malignancy, Cervical Cancer Trial (VB10.16, Atezolizumab Injection [Tecentriq],

Not yet recruiting
  • HPV-Related Cervical Carcinoma
  • +2 more
  • VB10.16
  • +2 more
  • (no location specified)
Oct 24, 2023

Adenocarcinoma, Pancreatic Ductal Trial in New York (Autogene cevumeran, Atezolizumab, mFOLFIRINOX)

Recruiting
  • Adenocarcinoma, Pancreatic Ductal
  • Autogene cevumeran
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 21, 2023

Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

Not yet recruiting
  • Locally Advanced Alveolar Soft Part Sarcoma
  • +9 more
  • Atezolizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 10, 2023

Hepatocellular Carcinoma Trial in Guangzhou (TACE-HACI, plus atezolizumab-bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • TACE-HACI, plus atezolizumab-bevacizumab
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 20, 2023

Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial

Not yet recruiting
  • Hepatocellular Carcinoma
  • BCLC Stage B Hepatocellular Carcinoma
  • Atezolizumab Injection
  • +2 more
  • (no location specified)
Mar 16, 2023